Pain medicine

Analgesic efficacy of inter-semispinal fascial plane block in Patients undergoing Cervical Spine Surgery through Posterior Approach: a randomized controlled trial

Anaesth Crit Care Pain MedPublished Randomised controlled trial

Authors' conclusion

Inter-semispinal plane block (ISPB) represents an effective analgesic technique and reduces opioid consumption in both intra- and postoperative settings. Moreover, the ISPB could significantly decrease opioid-associated side effects.

Study context

Population
Patients planned for cervical spine surgery via the posterior approach
Participants
52 patients
Comparison
Bilateral inter-semispinal plane block (ISPB) plus GA vs GA only
  • ISPBn = 26
  • Controln = 26reference
Primary endpoint
Total perioperative opioid consumption: co-primary intraoperative fentanyl and morphine consumption in first 24 h postoperatively
Methodological detailsprospective, 1:1 allocation
  • Prospective
  • 1:1 allocation

Primary result

As reported in the abstract

Intraoperative fentanyl and 24-h postoperative morphine

ISPB

175

median · range 110–220 · μg

Control

290

median · range 110–350 · μg

ISPB

7

median · range 5–12 · mg

Control

12

median · range 8–21 · mg

Secondary outcomes

Numerical rating scores (NRS) pain scores · first 12 h postoperatively

NRS significantly lower in ISPB vs control

Intraoperative mean arterial pressure (MAP) and HR

Significant MAP increase during surgery in control
P < 0.001
No significant MAP or HR differences between intraoperative time points in ISPB

Safety

Opioid side effects (nausea, vomiting, sedation)

Incidence significantly greater in control vs ISPB

Original publication

Analgesic efficacy of inter-semispinal fascial plane block in Patients undergoing Cervical Spine Surgery through Posterior Approach: a randomized controlled trial. Anaesth Crit Care Pain Med. Published 7 March 2023. doi:10.1016/j.accpm.2023.101213

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.